computed tomography [CT] , duplex scanning), and endovascular procedures were abstracted. The data from operative records, postoperative complications, mortality, and hospital stay were recorded. The results of any followup imaging study were noted, and the patency of the revascularization or the earliest date of symptom recurrence or mesenteric vascular disease recurrence were also recorded. The long-term follow-up information was obtained from the clinical records and from telephone interviews. The factors associated with survival were analyzed. Cause of death was determined from clinic records, autopsy findings, and death certificates. This study was approved by the Institutional Review Board of the Mayo Foundation.
For statistical analysis, the associations between perioperative mortality rate and risk factors were assessed univariately with two-sample t test, Wilcoxon rank sum test, and χ 2 test or Fisher exact test. The survival rate was estimated with the Kaplan-Meier method. Comparisons of survival curves were made with the log-rank test. A multivariate Cox proportional hazards model was constructed with factors found to be significantly associated with survival rate on univariate analysis results. All the tests were two-tailed. The test results were considered significant at a P value of less than .05.
RESULTS
Demographic data and risk factors. From January 1, 1990 , to December 31, 1999 , 58 patients underwent surgical intervention for AMI at the Mayo Clinic in Rochester, Minn. There were 36 women and 22 men (mean age, 67 years; range, 35 to 96 years). The cause of AMI was embolism in 16 patients (28%), thrombosis in 37 patients (64%), and NMI in five patients (9%). The patients with embolism, in comparison with the patients with thrombosis, were older (74 versus 63 years; P = .0027) and had a higher percentage of atrial fibrillation (50% versus 11%; P = .002; Table II ). Only two of the eight patients in the embolism group with atrial fibrillation were undergoing long-term anticoagulation therapy at presentation. Atherosclerosis was highly prevalent, and 64% of the patients had disease in two or more of the vascular distributions (Table II) .
The thrombosis group had a higher incidence rate of chronic mesenteric ischemia symptoms than did the embolism group (65% versus 6%; P = .001; Table II ). The mean duration of symptoms before the acute presentation was 8.2 months (median, 5.5 months). Fifteen patients (26%) had AMI within 6 weeks after a cardiac (n = 4 patients) or vascular operation (aortic, n = 3 patients; mesenteric, n = 3 patients; peripheral vascular procedures, n = 2 patients). Prior mesenteric reconstruction was performed in eight patients.
Clinical presentation. Fifty-five patients (95%) were seen with acute abdominal pain for a median of 24 hours duration and were available for preoperative evaluation (Appendix A, online only). Three patients were seen with shock with worsening acidosis and were taken immediately to the operating room for exploration. Nausea was the second most frequent symptom (44%), followed by vomiting and diarrhea (35% each). Sixteen percent of the patients had blood per rectum. The mean leukocyte count was elevated at 20.3 × 10 9 /mL; the count was abnormal in 98% of the tested patients and was more than 20 × 10 9 /mL in 50%. Lactate level was elevated in 91% of all the tested patients and was more than 3 mmol/L in 61% (Appendix B, online only).
Diagnostic evaluation. Aortography and selective mesenteric arteriography, if possible, were performed in 49 patients (84%), and results confirmed mesenteric arterial occlusive disease in all the cases (Appendix C, online only). A distinction between embolism and thrombosis could not always be made before surgery. Embolism was identified in 11 of the 13 studies (77%) and thrombosis in 33 of the 34 studies (97%). Arteriographic results confirmed occlusion of a previously placed graft in eight of eight studies (100%). Arteriography was used in the identification of NMI in two of five patients.
CT scanning was performed in 18 patients, and results confirmed superior mesenteric artery occlusion in 14 patients (78%; Appendix C, online only). Findings suggestive of bowel ischemia, including pneumatosis intestinalis, bowel wall thickening, ileus, and bowel dilatation, were seen in 11 patients (61%). Overall, 16 of the 18 CT scans (89%) had positive results that confirmed either arterial occlusion or bowel changes compatible with AMI. Duplex scan evaluation was performed in three patients, and results confirmed mesenteric vessel occlusion in two. (Table III) . Mesenteric revascularization was performed in 43 patients (bypass grafting, n = 22; thromboembolectomy, n = 19; patch angioplasty, n = 11; endarterectomy, n = 5; reimplantation, n = 2). Twentythree patients (40%) underwent second-look procedures. Bypass grafting was performed in 22 patients with thrombosis with polyester grafts in 17 patients (straight, n = 7; bifurcated, n = 10) and vein in five patients (straight, n = 4; bifurcated pantaloon graft, n = 1). The supraceliac aorta was used in 15 patients (celiac artery alone, n = 1; mesenteric alone, n = 5; celiac/hepatic and mesenteric, n = 9), and the infrarenal aorta was used in seven patients (all mesenteric).
Thirty-one patients underwent bowel resection during the first procedure. Of the 23 second-look procedures, 11 patients had bowel resections (further resection, n = 9; resection at second-look only, n = 2). Thirty-three patients underwent bowel resections at first-look or second-look laparotomy, and 16 of these patients had ostomies.
Morbidity rate. Major complications were frequent and occurred in 46 patients (79%; Appendix D, online only). Patients had a mean of 4.1 complications. Respiratory failure (36%) and multiorgan failure (31%) were the most frequent complications. Fifteen patients had suspected or known recurrent bowel infarction in the early postoperative period. Although seven patients underwent emergency bowel resection, eight additional patients received only supportive care for suspected or known recurrent bowel ischemia and a nonsalvageable condition. Only three of these 15 survived, and all the survivors underwent bowel resection. Reocclusion of the mesenteric arteries was documented in four patients and resulted in death in two patients. Three additional patients had embolism elsewhere: two to the lower limbs and one with diffuse mesenteric and systemic atheroembolism. There were seven myocardial infarctions, and 13 cardiac arrests. Eleven patients became ventilator-dependent. There was renal failure in nine patients (one patient needed dialysis), hepatic failure in nine patients, and two strokes. Gastrointestinal hemorrhage occurred in 12 patients.
Early mortality rate. The 30-day mortality rate was 32% (95% confidence interval [CI], 15% to 46%). The rate was 31% (95% CI, 4% to 51%) in patients with embolism, 32% (95% CI, 15% to 46%) in patients with thrombosis, and 80% (95% CI, 0 to 96%) in patients with NMI (embolism versus thrombosis, P value was not significant; embolism or thrombosis versus NMI, P < .001). Twentyfour patients died within 90 days (41%; 95% CI, 27% to 53%), and 23 patients died while still in the hospital. The causes of early death included multiorgan failure in 18 patients, mesenteric ischemia as the result of rethrombosis in two patients, myocardial infarction in two patients, chronic obstructive pulmonary disease in one patient, and unknown cause in one patient. Mesenteric ischemia contributed to multisystem organ failure in 12 of 18 patients (67%; Table IV ). The patients who died were older (mean age, 72 versus 63 years; P = .03). Age greater than or equal to 60 years resulted in a 54% mortality rate as com- pared with a rate of 12% for those patients who were younger than 60 years (P = .003). Age greater than or equal to 70 years was related to a 39% mortality rate as compared with a 26% rate for patients who were younger than 70 years (P = .01). Gender, revascularization, chronic mesenteric ischemia symptoms, and cardiovascular risk factors were not associated with early death. Having AMI as a complication of another surgery performed within 43 days was associated with increased mortality rate at 90 days (66% versus 36%; P = .03). Late results. The mean follow-up period was 529 days (range, 0 to 2877 days) and was complete. Recurrent symptoms occurred in 10 patients and included abdominal pain in six, diarrhea in five, and nausea and vomiting in two. Five patients had short bowel syndrome, and all were on long-term total parenteral nutrition (TPN). At last follow-up examination, 10 patients had weight gain (mean, 20 lbs), 12 had unchanged weights, and seven had weight loss (mean, 17 lbs). Follow-up imaging studies were obtained for 11 of 16 patients with prosthetic grafts (duplex scan, n = 5; arteriography, n = 3; CT scan, 2; magnetic resonance angiography, n = 1). Patency was demonstrated in nine grafts to a mean of 1.4 years. Two graft occlusions occurred at 21 and 136 days, and both were associated with recurrent mesenteric ischemia. One patient underwent surgical thrombectomy of the occluded bypass graft, and the other patient underwent percutaneous angioplasty. Both patients had symptom resolution. One patient died 1.5 years later of TPN line sepsis, and the other, also 1.5 years later, died of a cardiac arrhythmia. Two additional patients had superior mesenteric artery occlusive disease develop. Both refused reoperation, and both died at 131 and 176 days after symptom recurrence (Table IV) .
The overall survival rate (Fig 1) was 59% (95% CI, 47% to 73%) at 90 days, 43% (95% CI, 32% to 58%) at 1 year, and 32% (95% CI, 21% to 48%) at 3 years, which was significantly less than the rate for a white Midwestern control population (P < .001). The median survival time for all patients was 238 days. Survival analysis results by groups (Fig 2) showed significantly worse survival rate in the NMI group as compared with the rates in the embolism or thrombosis groups (P < .001). Six of 16 late deaths (38%) were attributable to mesenteric ischemia (Table V) .
Factors associated with survival rate. Univariate analysis results for factors associated with improved survival rate are listed in tion at first operation (P = .056), performance of arteriography (P = .074), and time to presentation greater than or equal to 24 hours (P = .085). When the association of time greater than 24 hours and bowel resection at first operation was analyzed, the results showed improved survival rate (P = .03). Survival rate was not significantly different whether the bypass graft was antegrade (n = 15 patients) or retrograde (n = 7 patients) or single (n = 12 patients) or double (n = 10 patients; P value not significant for all). No statistically significant association with improved survival rate was found with chronic mesenteric ischemia symptoms, second-look procedures, cardiac risk factors, and comorbid medical conditions. Variables found to be univariately associated with survival rate (age >60 years, recent surgery, bowel resection at first or second procedure) were entered into a multivariate analysis, and each was found to be independently associated with survival rate (Table VI) . Age older than 60 years increased mortality rate with a relative risk ratio of 3.0 (95% CI, 1.3 to 6.9; P = .009). Recent surgery increased the relative risk of mortality rate 2.4 times (95% CI, 1.2 to 4.9). Bowel resection at first-look or second-look procedure decreased mortality rate with a relative risk ratio of 0.5 (95% CI, 0.2 to 0.9).
DISCUSSION
AMI remains a morbid condition with poor shortterm and long-term survival rates. Although no population-based data have been published, the incidence rate of this lethal condition is increasing. In 1967 in an autopsy series, Ottinger and Austen 32 reported a rate of 8.8 cases of AMI per 10,000 hospital admission. Almost 30 years later, Stoney and Cunningham 33 observed an incidence rate of 1 in 1000 hospital admissions. As the mean age of the population increases and the proportion of older patients in our hospitals grows, AMI will predictably be more common. Unfortunately, as reported in other series as well, mortality rate in older patients is significantly greater and carries a relative risk of mortality rate of 3.0 for those more than the age of 60 years.
Early recognition of AMI is crucial because irreversible bowel necrosis develops in many patients by the time of abdominal exploration. Fifty-seven percent of our patients needed bowel resection at the time of the first operation, and no resection was performed because of an unsalvageable situation with excessive bowel necrosis in an additional 5%. A high index of clinical suspicion is needed, and our data concur with the classic teaching of pain out of proportion to physical findings. Pain was present in 95% of our patients, but signs of frank peritonitis were frequently late or absent. Abdominal distension and motility problems, such as nausea, vomiting, or constipation, were more frequent. Laboratory abnormalities were present in 98% of our patients, particularly leukocytosis and high lactate levels. Unfortunately, none of these findings is specific for AMI. CT scanning and contrast arteriography continue to play a major role in the diagnosis of AMI. [34] [35] [36] [37] [38] CT scanning has been reported to be sensitive in the diagnosis of mesenteric occlusion, 39, 40 and our findings are in agreement. CT scan results confirmed mesenteric arterial occlusion or suggested ischemic bowel in 89% of the patients studied. This imaging method also allows the identification of nonvascular causes of acute abdominal pain. CT scan with three-dimensional reconstruction is an increasingly useful technique, which may allow identification of vascular anatomy and pathology with good enough detail for diagnosis and operative planning.
Contrast arteriography plays an important role in early diagnosis and is helpful in planning and initiating treatment. 29, 38 We found that arteriographic results confirmed mesenteric vascular disease in 100% of the cases and correctly identified thrombosis or embolism in 94%. Endovascular interventions or catheter-directed vasodilator therapy can be started immediately after arteriography.
The role of endovascular therapy in AMI continues to be limited and somewhat controversial. Boley and others 29 43 Undoubtedly, the number of endovascular interventions, angioplasty, and stenting for both acute and chronic mesenteric occlusive disease will increase in the future. In AMI, potential advantages include the chance to replace or decrease the need for open surgical reconstructions of the occluded arteries, performed not infrequently with prosthetic grafts in a potentially or de facto infected field. Our experience with catheter-based reconstructions in AMI is limited, and only two patients had such treatment in this series, with good results in one.
JOURNAL OF VASCULAR SURGERY
The goal of surgical care in AMI is the removal of nonsalvageable bowel, the minimization and prevention of further bowel infarction, and the preservation of small intestinal length. The surgical procedure involves assessment of bowel viability, determination or confirmation of the underlying cause, revascularization, and resection of infarcted bowel. Second-look procedures allow for the reassessment of bowel viability and further bowel resection as needed. Exploratory laparotomy (open or laparoscopic) remains the gold standard for the determination of bowel viability, and an operation is the only way to remove dead bowel. Bowel viability is assessed with physical examination (inspection, palpation), hand-held Doppler scan examination, 44 and intravenous injection of fluorescein. 10 Absent, perivascular, or patchy fluorescein patterns are considered positive for impaired perfusion. Because some of these perfusion problems are reversible, the sensitivity and predictive value of positive test results at first operation do not negate the value of a second-look procedure. 45 The most useful surgical revascularization technique in embolism remains the balloon catheter thromboembolectomy, with or without patch angioplasty of the superior mesenteric artery. Patients with chronic proximal occlusion or stenosis undergo revascularization with an aortomesenteric or, less frequently, iliomesenteric bypass graft. Good results have been reported for both multivessel 46 and single-vessel reconstruction 12 in both the acute and chronic settings. Equally good results were obtained in this study when revascularization was performed from a supraceliac aortic origin or from a retrograde position, regardless of whether it was performed to one or two vessels. In AMI, most surgeons in our group favor single-vessel reconstruction now to the superior mesenteric artery, performed frequently in a retrograde fashion that is simpler to perform in the acute setting. In patients with bowel perforation, a saphenous vein or rifampin-soaked polyester graft is our choice for conduit.
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Resection of the infarcted bowel is performed after revascularization. In our series, 48% of the patients needed an ostomy. Patients with bowel of questionable viability undergo a second-look procedure, usually within 24 hours. The decision to reoperate is made during the first operation and is independent of the clinical status of the patient during the two procedures. The utility of secondlook procedures was shown in other studies and in ours as well. Of our patients who underwent second-look procedures, 48% needed bowel resection.
Resection of bowel in either first-look or second-look procedures was associated with improved survival rate on univariate and multivariate analysis results and was associated with a risk reduction of 0.5. Resectability may represent a selection process of patients who had clearly demarcated necrotic and conversely remaining viable bowel, and the unresected group included both the nonsalvageable cases (n = 3 patients) and patients whose conditions subsequently deteriorated (n = 8 patients) but did not undergo operation (ie, resectability may be a marker for improved survival rate). There may also be a causal relationship between bowel resection and improved survival rate, but this cannot be determined from these retrospective data.
Major postoperative complications remain excessive, and both early and late mortality rates continue to be high. Multiorgan failure is the most lethal complication, and it is the result of a combination of bowel ischemia, sepsis, and generalized atherosclerosis because many patients are elderly with several cardiovascular risk factors. Recurrent and persistent mesenteric ischemia remains a major threat to these patients and contributes significantly to the early and late mortality rates. Successful revascularization, therefore, remains imperative and likely contributes to the reduction of mortality rate to the 30% range in the embolism or thrombosis group from the 60% to 70% range reported earlier in several studies. Age less than 60 years and removal of the dead bowel were factors in our multivariate analysis that predicted improved survival rate.
Prevention of AMI may be an effective way to reduce the high mortality rate of this lethal disease. In some patients with underlying mesenteric atherosclerosis, AMI could clearly be prevented with recognition and timely, elective revascularization for symptoms of chronic mesenteric occlusive disease, with much lower morbidity and mortality rates. 12, 46, 47 Almost half of the patients in our series had prior symptoms of chronic mesenteric ischemia. Our data also support treatment of atrial fibrillation with anticoagulation therapy. Seventy-five percent of the patients with mesenteric embolism were not undergoing anticoagulation therapy with heparin or warfarin sodium at the time of the ischemic event.
In conclusion, contemporary management of AMI should include a high index of clinical suspicion, rapid preoperative evaluation, revascularization with open surgical techniques, resection of nonviable bowel, the liberal use of second-look procedures, sophisticated postoperative care for the prevention of multiorgan failure, and the recognition of recurrent mesenteric ischemia. Although overall clinical outcome is still poor, such management will result in the early survival of two thirds of the patients with embolism and thrombosis. Older patients, those who did not undergo bowel resection, and those with NMI have the highest mortality rates. Long-term survival rate remains dismal because of the underlying cardiovascular disease and recurrent mesenteric ischemia and shows how much needs to be done to prevent and treat this lethal disease. Timely revascularization of symptomatic patients with chronic mesenteric occlusive disease could be one effective way to decrease the incidence and subsequent high mortality rates of AMI.
